Loading clinical trials...
Loading clinical trials...
Bleeding of Unknown Cause, Insight Into a Multifactorial Bleeding Disorder: a Swiss Case-control Study
The goal of this prospective cohort is to identified specific biological patterns in patients with a bleeding of unknown cause and to study the specific mechanisms of the bleeding disorder for each subset of patients.
Patients with bleeding of unknown cause are included. At baseline, blood will be drawn to evaluate the hemostatic profile. Findings are compared to a control group of healthy individuals. Patients and controls are followed for 3 years.
Age
16 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Ospedale Regionale di Bellinzona
Bellinzona, Switzerland
Inselspital - Universitätsspital Bern
Bern, Switzerland
University Hospital
Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
Gruppo Ospedaliero Moncucco
Lugano, Switzerland
Kantonsspital St.Gallen
Sankt Gallen, Switzerland
USZ - Universitätsspital Zürich
Zurich, Switzerland
Start Date
April 1, 2023
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2027
Last Updated
December 16, 2024
400
ESTIMATED participants
Thrombin generation
DIAGNOSTIC_TEST
Fibrinolysis
DIAGNOSTIC_TEST
Fibrin clot structure
DIAGNOSTIC_TEST
Coated platelets
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital, Geneva
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04676880